Hi Gg,

Thanks for catching this. We will correct the error when we update the report to include outcomes of the consensus call.

Kind regards,

Emily

From: Gnso-newgtld-wg <gnso-newgtld-wg-bounces@icann.org> on behalf of "Levine, Gertrude via Gnso-newgtld-wg" <gnso-newgtld-wg@icann.org>
Reply to: "Levine, Gertrude" <glevine@nabp.pharmacy>
Date: Tuesday, 5 January 2021 at 23:48
To: Jeff Neuman <jeff@jjnsolutions.com>, "Cheryl Langdon-Orr (cheryl@hovtek.com.au)" <cheryl@hovtek.com.au>, "gnso-newgtld-wg@icann.org" <gnso-newgtld-wg@icann.org>
Subject: [Gnso-newgtld-wg] Minor error in SubPro report

Hi Jeff and Cheryl,

I have come across what appears to be a minor error in the SubPro final report. In the Summary of Outcomes on pages 267-268, Recommendation 9.1 references Specification 11 3(a)-(d) and includes footnote #295, which lists the relevant sections. However, the footnote lists what should be sections (a)-(d) as sections (e)-(f). The corresponding footnote in the body of the report on pages 37-38 lists the sections correctly.

Best regards,

Gertrude “Gg” Levine

Digital Health Manager

847/391-4497

National Association of Boards of Pharmacy

1600 Feehanville Dr, Mount Prospect, IL 60056